Alicia K. Morgans, M.D.

Assistant Professor
Faculty Appointments
Assistant Professor of Medicine
M.P.H., Public Health , Vanderbilt University, Nashville, TennesseeM.D., MEDICINE, University of Pennsylvania, Philadelphia, Pennsylvania
Office Address
2220 Pierce Ave.
777 Preston Research Building
Nashville, TN 37232
Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur. Urol [print-electronic]. 2015 Jun; 67(6): 1019-25. PMID: 25174325, PMCID: PMC4412750, PII: S0302-2838(14)00788-X, DOI: 10.1016/j.eururo.2014.08.035, ISSN: 1873-7560.

Johnson DB, Friedman DL, Berry E, Decker I, Ye F, Zhao S, Morgans AK, Puzanov I, Sosman JA, Lovly CM. Survivorship in Immune Therapy: Assessing Chronic Immune Toxicities, Health Outcomes, and Functional Status among Long-term Ipilimumab Survivors at a Single Referral Center. Cancer Immunol Res [print-electronic]. 2015 May; 3(5): 464-9. PMID: 25649350, PMCID: PMC4420706, PII: 2326-6066.CIR-14-0217, DOI: 10.1158/2326-6066.CIR-14-0217, ISSN: 2326-6074.

Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Resnick MJ, Barocas DA, Penson DF. Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy. J. Urol [print-electronic]. 2015 Apr; 193(4): 1226-31. PMID: 25451829, PMCID: PMC4542148, PII: S0022-5347(14)04835-6, DOI: 10.1016/j.juro.2014.11.006, ISSN: 1527-3792.

Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, Morgans AK, Penson DF. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. J. Clin. Oncol [print-electronic]. 2015 Mar 3/20/2015; 33(9): 1078-85. PMID: 25667275, PII: JCO.2014.60.2557, DOI: 10.1200/JCO.2014.60.2557, ISSN: 1527-7755.

Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Penson DF. Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. Prostate Cancer Prostatic Dis [print-electronic]. 2014 Dec; 17(4): 338-42. PMID: 25134939, PMCID: PMC4227957, PII: pcan201431, DOI: 10.1038/pcan.2014.31, ISSN: 1476-5608.

Lipworth L, Morgans AK, Edwards TL, Barocas DA, Chang SS, Herrell SD, Penson DF, Resnick MJ, Smith JA, Clark PE. Renal cell cancer histological subtype distribution differs by race and sex. BJU Int [print-electronic]. 2014 Oct 10/13/2014; PMID: 25307281, DOI: 10.1111/bju.12950, ISSN: 1464-410X.

Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment. Cancer [print-electronic]. 2014 Apr 4/15/2014; 120(8): 1263-71. PMID: 24510400, DOI: 10.1002/cncr.28563, ISSN: 1097-0142.

Barocas DA, Chen V, Cooperberg M, Goodman M, Graff JJ, Greenfield S, Hamilton A, Hoffman K, Kaplan S, Koyama T, Morgans A, Paddock LE, Phillips S, Resnick MJ, Stroup A, Wu XC, Penson DF. Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res. 2013 Jul; 2(4): 445-60. PMID: 24236685, DOI: 10.2217/cer.13.34, ISSN: 2042-6313.

Morgans AK, Smith MR. Bone-targeted agents: preventing skeletal complications in prostate cancer. Urol. Clin. North Am [print-electronic]. 2012 Nov; 39(4): 533-46. PMID: 23084529, PMCID: PMC3721069, PII: S0094-0143(12)00057-2, DOI: 10.1016/j.ucl.2012.07.009, ISSN: 1558-318X.